Showing 1-10 of 27 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Expanded data mining of accumulated functional genomics data for identifying mechanistic biomarkers informative of T1D risk and prevention | Adelaide University | Megan Penno | Cures | 01-June-2024 to 31-May-2027 | $444,306.96 |
| Using Multi-omics to turn islet autoimmunity driver genes into therapies | Adelaide University | Simon Barry | Cures | 01-August-2024 to 31-July-2027 | $446,624.00 |
| Finding T1D driver genes: Targets for future therapies | Adelaide University | Ying Wong | Cures | 01-March-2024 to 28-February-2027 | $267,920.00 |
| Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus free features in adults with Type 1 Diabetes | Baker Heart & Diabetes Institute | Neale Cohen | Improving Lives | 01-October-2022 to 28-February-2026 | $746,100.00 |
| Induction of beta-cell regeneration using EZH2 inhibitors | Baker Heart & Diabetes Institute | Sam El-Osta | Cures | 01-October-2023 to 31-August-2026 | $699,447.00 |
| End Diabetes Stigma: Global Summit | Deakin University | Jane Speight | Improving Lives | 01-March-2025 to 28-February-2027 | $500,000.00 |
| Providing blood glucose monitoring, HbA1c testing, and other in-country support to centers enrolled in the Life for a Child Program | Diabetes Australia (fka Diabetes New South Wales) | Graham Ogle | Transportfolio | 01-March-2025 to 30-September-2026 | $1,266,667.00 |
| Combination immunotherapy with abatacept and nasal insulin | Melbourne Health | John Wentworth | Cures | 01-February-2022 to 30-June-2025 | $575,000.00 |
| Targeted regulatory T cells to treat type 1 diabetes | Monash University | Joshua Ooi | Cures | 01-February-2023 to 31-January-2026 | $510,000.00 |
| α-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes | Monash University | Michael Cowley | Improving Lives | 01-August-2019 to 30-September-2025 | $716,962.40 |